Filtered By:
Source: Neurocritical Care
Condition: Hemorrhagic Stroke
Drug: Lortab
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Safety and Feasibility of a Novel Transnasal Cooling Device to Induce Normothermia in Febrile Cerebrovascular Patients
ConclusionsInducing normothermia with a novel transnasal TMD appears to be safe, feasible and not associated with significant shivering. A multicenter trial testing the ability of the CoolStat to maintain normothermia for 24 h is currently underway.
Source: Neurocritical Care - July 13, 2020 Category: Neurology Source Type: research
